These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 38923421

  • 1. Autophagy regulates bone loss via the RANKL/RANK/OPG axis in an experimental rat apical periodontitis model.
    Wu Z, Duan S, Li M, Zhang A, Yang H, Luo J, Cheng R, Hu T.
    Int Endod J; 2024 Sep; 57(9):1315-1325. PubMed ID: 38923421
    [Abstract] [Full Text] [Related]

  • 2. Correlation between PD-1/PD-L1 and RANKL/OPG in chronic apical periodontitis model of Sprague-Dawley rats.
    Wang Q, Wang L, Sheng L, Zhang B, Jieensi B, Zheng S, Liu Y.
    Odontology; 2024 Oct; 112(4):1113-1122. PubMed ID: 38528238
    [Abstract] [Full Text] [Related]

  • 3. The receptor activator of NF-κB ligand-osteoprotegerin system in pulpal and periapical disease.
    Belibasakis GN, Rechenberg DK, Zehnder M.
    Int Endod J; 2013 Feb; 46(2):99-111. PubMed ID: 22900632
    [Abstract] [Full Text] [Related]

  • 4. [Effects of chitosan oligosaccharide on alveolar bone resorption, Th17/Treg balance and OPG/RANKL/RANK pathway in periodontitis rats].
    Zhang L, Liu YS, Wu YF, Fu QY.
    Shanghai Kou Qiang Yi Xue; 2021 Jun; 30(3):237-242. PubMed ID: 34476437
    [Abstract] [Full Text] [Related]

  • 5. Immune-Inflammatory Cell Profile and Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin Expression in Persistent Apical Periodontitis after Root Canal Retreatment Failure.
    Estrela C, Decurcio Dde A, Silva JA, Batista AC, de Souza Lima NC, de Freitas Silva BS, de Souza JA, Souza Costa CA.
    J Endod; 2016 Mar; 42(3):439-46. PubMed ID: 26806398
    [Abstract] [Full Text] [Related]

  • 6. Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts.
    Armada L, Marotta Pdos S, Pires FR, Siqueira JF.
    J Endod; 2015 Aug; 41(8):1281-7. PubMed ID: 25956608
    [Abstract] [Full Text] [Related]

  • 7. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.
    Jin Q, Cirelli JA, Park CH, Sugai JV, Taba M, Kostenuik PJ, Giannobile WV.
    J Periodontol; 2007 Jul; 78(7):1300-8. PubMed ID: 17608585
    [Abstract] [Full Text] [Related]

  • 8. Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway.
    Hou JM, Xue Y, Lin QM.
    Acta Pharmacol Sin; 2012 Oct; 33(10):1277-84. PubMed ID: 22902986
    [Abstract] [Full Text] [Related]

  • 9. Levels of oxidative stress biomarkers and bone resorption regulators in apical periodontitis lesions infected by Epstein-Barr virus.
    Jakovljevic A, Andric M, Nikolic N, Coric V, Krezovic S, Carkic J, Knezevic A, Beljic-Ivanovic K, Pljesa-Ercegovac M, Miletic M, Soldatovic I, Radosavljevic T, Jovanovic T, Simic T, Ivanovic V, Milasin J.
    Int Endod J; 2018 Jun; 51(6):593-604. PubMed ID: 29315650
    [Abstract] [Full Text] [Related]

  • 10. [Electroacupuncture Intervention Improves Cartilage Degeneration and Subchondral Bone Osteoporosis of Knee-joint Possibly by Adjusting OPG/RANK/RANKL Signaling in Ovariectomized Rats].
    Sun GH, Liao Y, Liao Y, Ni ZY, Li N, Zhong PR, Li XH, Zhou J.
    Zhen Ci Yan Jiu; 2018 Dec 25; 43(12):781-7. PubMed ID: 30585456
    [Abstract] [Full Text] [Related]

  • 11. Association between bacteria occurring in the apical canal system and expression of bone-resorbing mediators and matrix metalloproteinases in apical periodontitis.
    Takahama A, Rôças IN, Faustino ISP, Alves FRF, Azevedo RS, Gomes CC, Araújo-Filho WR, Siqueira JF.
    Int Endod J; 2018 Jul 25; 51(7):738-746. PubMed ID: 29363148
    [Abstract] [Full Text] [Related]

  • 12. Oral Exposure to ZnO Nanoparticles Disrupt the Structure of Bone in Young Rats via the OPG/RANK/RANKL/IGF-1 Pathway.
    Xu X, Tang Y, Lang Y, Liu Y, Cheng W, Xu H, Liu Y.
    Int J Nanomedicine; 2020 Jul 25; 15():9657-9668. PubMed ID: 33299310
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Production of Soluble Receptor Activator of Nuclear Factor Kappa-Β Ligand and Osteoprotegerin by Apical Periodontitis Cells in Culture and Their Modulation by Cytokines.
    Duka M, Eraković M, Dolićanin Z, Stefanović D, Čolić M.
    Mediators Inflamm; 2019 Jul 25; 2019():8325380. PubMed ID: 31011287
    [Abstract] [Full Text] [Related]

  • 15. [Expression of receptor activator of nuclear factor kappaB ligand and osteoprotegerin in chronic apical periodontitis].
    Fan R, Zhang CF, Gao Y.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Feb 18; 40(1):39-42. PubMed ID: 18278135
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis.
    Araújo AA, Lopes de Souza G, Souza TO, de Castro Brito GA, Sabóia Aragão K, Xavier de Medeiros CA, Lourenço Y, do Socorro Costa Feitosa Alves M, Fernandes de Araújo R.
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Oct 18; 386(10):875-84. PubMed ID: 23775504
    [Abstract] [Full Text] [Related]

  • 18. Melittin Treats Periprosthetic Osteolysis in a Rat Model by Inhibiting the NF-kB Pathway and Regulating the Ratio of Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin.
    Niu J, Bi F, Tian Q, Tian K.
    J Arthroplasty; 2024 Jul 18; 39(7):1845-1855. PubMed ID: 38336308
    [Abstract] [Full Text] [Related]

  • 19. Differential patterns of receptor activator of nuclear factor kappa B ligand/osteoprotegerin expression in human periapical granulomas: possible association with progressive or stable nature of the lesions.
    Menezes R, Garlet TP, Letra A, Bramante CM, Campanelli AP, Figueira Rde C, Sogayar MC, Granjeiro JM, Garlet GP.
    J Endod; 2008 Aug 18; 34(8):932-8. PubMed ID: 18634923
    [Abstract] [Full Text] [Related]

  • 20. S-amlodipine improves endothelial dysfunction via the RANK/RANKL/OPG system by regulating microRNA-155 in hypertension.
    Yang J, Si D, Zhao Y, He C, Yang P.
    Biomed Pharmacother; 2019 Jun 18; 114():108799. PubMed ID: 30951948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.